Papers authored by De Portu S

Collect these papers and discover other ones on Labmeeting. Learn more.
Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact.
+ cite this
+ View Abstract
Di Micco L, Torraca S, Pota A, Di Giuseppe D, Pisani A, Spinelli L, De Portu S, Sabbatini M, Mantovani L, and Cianciaruso B
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 24(11):3434-40, 2009 Nov - Who cited this? | PubMed ID: 19531671 | Fulltext
Recommend
Psoriatic arthritis: pharmacoeconomic considerations.
+ cite this
+ View Abstract
Olivieri I, Mantovani LG, D'Angelo S, Padula A, and de Portu S
Current rheumatology reports 11(4):263-9, 2009 Aug - Who cited this? | PubMed ID: 19691929 | Fulltext
Recommend
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients.
+ cite this
+ View Abstract
Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, Longhi M, Sitia S, Bianchi M, Ferrario P, Doria A, De Gennaro Colonna V, and Sarzi-Puttini P
Rheumatology (Oxford, England) 48(7):834-9, 2009 Jul - Who cited this? | PubMed ID: 19465588 | Fulltext
Recommend
Emerging role of capecitabine in gastric cancer.
+ cite this
+ View Abstract
Comella P, Franco L, Casaretti R, de Portu S, and Menditto E
Pharmacotherapy 29(3):318-30, 2009 Mar - Who cited this? | PubMed ID: 19249950 | Fulltext
Recommend
Notification of undesirable effects of cosmetics and toiletries.
+ cite this
+ View Abstract
Sportiello L, Cammarota S, de Portu S, and Sautebin L
Pharmacological research : the official journal of the Italian Pharmacological Society 59(2):101-6, 2009 Feb - Who cited this? | PubMed ID: 19028583 | Fulltext
Recommend
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.
+ cite this
+ View Abstract
Olivieri I, de Portu S, Salvarani C, Cauli A, Lubrano E, Spadaro A, Cantini F, Cutro MS, Mathieu A, Matucci-Cerinic M, Pappone N, Punzi L, Scarpa R, Mantovani LG, and PACE working group
Rheumatology (Oxford, England) 47(11):1664-70, 2008 Nov - Who cited this? | PubMed ID: 18725374 | Fulltext
Recommend
Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome.
+ cite this
+ View Abstract
Sarzi-Puttini P, Atzeni F, Di Franco M, Lama N, Batticciotto A, Iannuccelli C, Dell'Acqua D, de Portu S, Riccieri V, Carrabba M, Buskila D, Doria A, and Valesini G
Autoimmunity 41(1):74-9, 2008 Feb - Who cited this? | PubMed ID: 18176867 | Fulltext
Recommend
The pharmacoeconomic impact of amlodipine use on coronary artery disease.
+ cite this
+ View Abstract
De Portu S, Menditto E, Scalone L, Bustacchini S, Cricelli C, and Mantovani LG
Pharmacological research : the official journal of the Italian Pharmacological Society 54(2):158-63, 2006 Aug - Who cited this? | PubMed ID: 16814560 | Fulltext
Recommend
Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.
+ cite this
+ View Abstract
Rossetti F, De Portu S, Menditto E, Scalone L, Bustacchini S, Cricelli C, and Mantovani LG
Pharmacological research : the official journal of the Italian Pharmacological Society 53(3):197-201, 2006 Mar - Who cited this? | PubMed ID: 16406672 | Fulltext
Recommend
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.
+ cite this
+ View Abstract
Atzeni F, Sarzi-Puttini P, Dell' Acqua D, de Portu S, Cecchini G, Cruini C, Carrabba M, and Meroni PL
Arthritis research & therapy 8(1):R3, 2006 - Who cited this? | PubMed ID: 16356192 | Fulltext
Recommend
Cost-effectiveness analysis of bisoprolol treatment for heart failure.
+ cite this
+ View Abstract
Di Stasi F, Scalone L, De Portu S, Menditto E, and Mantovani LG
Italian heart journal : official journal of the Italian Federation of Cardiology 6(12):950-5, 2005 Dec - Who cited this? | PubMed ID: 16502708 | Fulltext
Recommend
Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study.
+ cite this
+ View Abstract
Atzeni F, Ardizzone S, Sarzi-Puttini P, Colombo E, Maconi G, De Portu S, Carrabba M, and Bianchi Porro G
Alimentary pharmacology & therapeutics 22(5):453, 2005 Sep 1 - Who cited this? | PubMed ID: 16128684 | Fulltext
Recommend



Search Google Scholar for De Portu S

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!